Albumin formulation and use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10844349
APP PUB NO 20140234966A1
SERIAL NO

14130639

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a new formulation of albumin, a method for producing the albumin formulation and to uses of the albumin formulation, for example in cell culture such as mammalian cell culture and particularly in stem cell culture.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ALBUMEDIX LTD

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dimasi, Luke Boston, US 1 2
Merkel, Sandra Marie Raleigh, US 1 2
Morton, Philip Harvey Nottingham, GB 5 41
Sheahan, Collette Ann Birkenhead, AU 1 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 24, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 24, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00